No article text was recorded for this version.
post-treatment surveillance duration
Version 1 of 123 papers30 conceptsfrozen 2026-10-04
Papers in this version
- Blog: The Clinical Study of Primary Malignant Tumors in Both the Lung and Larynx
- Blog: Trends and age, sex, and race disparities in time to second primary cancer from 1990 to 2019
- Blog: Risk and Prognosis of Secondary Bladder Cancer After Radiation Therapy for Rectal Cancer: A Large Population-Based Cohort Study
- Blog: Clinicopathological profile of patients with brain secondaries from Ca cervix: a case series of five patients from tertiary cancer centre in North India
- Blog: The Impact of Tirzepatide on Cancer Development: a literature review
- Blog: Life years lost by childhood cancer treatment and health related late effects among childhood cancer survivors
- Blog: Association of Radiotherapy for Rectal Cancer and Second Gynecological Malignant Neoplasms
- Blog: Renal cell carcinoma in chronic hemodialysis patients. A 1990 questionnaire study and review of past questionnaires.
- Blog: Development of Randomized Trials in Adults with Medulloblastoma-The Example of EORTC 1634-BTG/NOA-23
- Blog: Second Primary Renal Cell Carcinoma With Nonrenal Malignancies: An Analysis of 118 Cases and a Review of Literature
- Blog: Cause of death during nasopharyngeal carcinoma survivorship: a population-based analysis
- Blog: Characteristics and Outcomes of Second Primary Multiple Myeloma in Adult Cancer Survivors: A Population‐Based Cohort Study
- Blog: Renal cell carcinoma in chronic hemodialysis patients-a 1992 questionnaire study.
- Blog: Second primary malignancies in cervical cancer and endometrial cancer survivors: a population-based analysis
- Blog: PRIMARY LIVER CANCER : NATURAL TOXINS AND PREVENTION IN CHINA
- Blog: Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors
- Blog: A comprehensive analysis of renal cell carcinoma as first and second primary cancers
- Blog: The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
- Blog: Evaluation of Internet-based pharmaceutical care effect on young and middle-aged patients with hypertension by the principal component analysis and the Markov cohort during COVID-19 pandemic
- Blog: Efficacy of Vaccination against HPV Infections to Prevent Cervical Cancer in France: Present Assessment and Pathways to Improve Vaccination Policies
- Blog: Risk and Prognosis of Secondary Rectal Cancer After Radiation Therapy for Pelvic Cancer
- Blog: Analysis of prognosis and treatment decisions for patients with second primary lung cancer following esophageal cancer
- Blog: Using artificial intelligence to predict and prevent non-cancer mortality in patients with cancer: ARILIS study protocol
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_post_treatment_surveillance_duration_b74cbcc2,
title = {post-treatment surveillance duration},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/post-treatment-surveillance-duration/rdr_b74cbcc214ea432d937eba33a49c1050},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_post_treatment_surveillance_duration_b74cbcc2_v1,
title = {post-treatment surveillance duration},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/post-treatment-surveillance-duration/rdr_b74cbcc214ea432d937eba33a49c1050/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}